Potential Cost‐Saving Model Utilizing Mark Cuban Cost Plus Drug Company for Purchasing Common Otolaryngology Medications
Year: 2024
Type: article
Source: Otolaryngology
DOI: 10.1002/ohn.1058
Authors: Zachary Buxo, John D. Cramer
Institution: Wayne State University
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W4404504659
